{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:40:50Z","timestamp":1759412450401},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/inf.0000000000000752","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T01:39:00Z","timestamp":1431481140000},"page":"884-892","source":"Crossref","is-referenced-by-count":13,"title":["First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers"],"prefix":"10.1097","volume":"34","author":[{"given":"Denis","family":"Crevat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job D.","family":"Brion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Gailhardou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thelma M.","family":"Laot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosario","family":"Capeding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4161\/hv.21224","article-title":"Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore.","volume":"8","author":"Leo","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/INF.0b013e3181fe05af","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-naive children, adolescents, and adults in Mexico City: randomized controlled phase 1 trial of safety and immunogenicity.","volume":"30","author":"Poo","year":"2011","journal-title":"Pediat Infect Dis J"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.vaccine.2012.07.043","article-title":"Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru.","volume":"30","author":"Lanata","year":"2012","journal-title":"Vaccine"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"R12-19-20210202","first-page":"162","article-title":"Safety and immunogenicity of recombinant, live attenuated tetravalent dengue vaccine (CYD-TDV) in healthy Vietnamese adults and children.","volume":"3","author":"Tran","year":"2012","journal-title":"J Vaccines Vaccin"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America.","volume":"372","author":"Villar","year":"2015","journal-title":"N Engl J Med"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4269\/ajtmh.2011.11-0125","article-title":"Decay and persistence of maternal dengue antibodies among infants in Bangkok.","volume":"85","author":"van Panhuis","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.","volume":"151","author":"Mantel","year":"2008","journal-title":"J Virol Methods"},{"key":"R20-19-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","article-title":"Optimization and validation of a plaque reduction neutralization test for the detection of neutralizing antibodies to four serotypes of dengue virus used in support of dengue vaccine development.","volume":"88","author":"Timiryasova","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"R21-19-20210202","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1542\/peds.2014-0690","article-title":"Etiologies for seizures around the time of vaccination.","volume":"134","author":"Verbeek","year":"2014","journal-title":"Pediatrics"},{"key":"R22-19-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children.","volume":"167","author":"Rowhani-Rahbar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"R24-19-20210202","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Collaborative Group for the Study of Yellow Fever Vaccines. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine"},{"key":"R25-19-20210202","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.vaccine.2014.02.085","article-title":"Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.","volume":"32","author":"Huang","year":"2014","journal-title":"Vaccine"},{"key":"R26-19-20210202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006454-199901000-00011","article-title":"Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.","volume":"18","author":"Usonis","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R27-19-20210202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00006454-200206000-00014","article-title":"Kaiser Permanente Medical Team for Varivax. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R28-19-20210202","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/INF.0b013e31822256a5","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with measles-mumps-rubella and varicella vaccines in children less than 2 years of age.","volume":"30","author":"Rinderknecht","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:21Z","timestamp":1620954441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201508000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000752","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}